Gilead Sciences, Inc. ( GILD) - Stock Earnings
GILD Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 3.1 billion USD | 7.8 billion USD |
| 2025Q4 | 2.2 billion USD | 7.9 billion USD |
| 2026Q1 | 2.0 billion USD | 7.0 billion USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
GILD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 5.7 billion USD | 27.1 billion USD |
| 2024 | 480.0 million USD | 28.8 billion USD |
| 2025 | 8.5 billion USD | 29.4 billion USD |
| 2026 Est. | — | — |
GILD
List: Contenders
Price: $128.99
Dividend Yield: 2.47%
Forward Dividend Yield: 2.54%
Payout Ratio: 375.61%
Dividend Per Share: 3.19 USD
Earnings Per Share: 7.34 USD
P/E Ratio: 18.13
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 2.7 million
Ebitda: 2.4 billionMarket Capitalization: 160.2 billion
Average Dividend Frequency: 4
Years Paying Dividends: 12
DGR3: 2.70%
DGR5: 3.56%
DGR10: 30.00%